Simple, rapid enzyme-linked immunosorbent assay (ELISA) for the determination of rat osteocalcin

被引:9
作者
Fu, JY [1 ]
Muller, D [1 ]
机构
[1] Bayer Corp, Inst Bone & Joint Disorders & Canc, W Haven, CT 06516 USA
关键词
bone; bone GLA protein; osteoporosis; radioimmunoassay; ovariectomy;
D O I
10.1007/s002239900608
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Determination of the concentration of osteocalcin in rat serum is frequently performed using a commercially available radioimmunoassay (RIA). However, this assay takes 3 days to complete, uses radioactive material, and has a narrow linear range. The limited range of the RIA makes it necessary to test multiple dilutions of the sample which frequently results in values that differ, depending on the dilution. In order to overcome these limitations, we have developed an ELISA that utilizes the same standards and anti-rat osteocalcin antiserum, as is used in the RIA. The principle of the ELISA is that the osteocalcin in the sample competes with osteocalcin previously immobilized on a microtiter plate to bind to the available anti-rat osteocalcin antibodies, The amount of antibody bound to the immobilized osteocalcin is determined colorimetrically using a secondary antibody coupled to alkaline phosphatase. This ELISA has a three-log linear response with a sensitivity of 0.1-0.15 ng/ml and intra- and interassay coefficient of variance (CV) values of less than 10%. Most importantly, the assay is rapid and only requires a 2-hour incubation of the sample with the antiserum. The incubation time is important since we and others have observed a significant decrease in the osteocalcin level from serum samples incubated for long periods of time with the antiserum, presumably due to degradation of the osteocalcin. In general, the commercially available RIA gives osteocalcin values that are one-half to one-fourth that of the ELISA because the RTA requires a 48-hour incubation time.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 16 条
[1]  
BROWN JP, 1984, LANCET, V1, P1091
[2]  
DIEGO EMD, 1994, CLIN CHEM, V40, P2071
[3]   Increased bone formation in osteocalcin-deficient mice [J].
Ducy, P ;
Desbois, C ;
Boyce, B ;
Pinero, G ;
Story, B ;
Dunstan, C ;
Smith, E ;
Bonadio, J ;
Goldstein, S ;
Gundberg, C ;
Bradley, A ;
Karsenty, G .
NATURE, 1996, 382 (6590) :448-452
[4]   SANDWICH IMMUNOASSAY SPECIFIC FOR THE N-TERMINAL SEQUENCE OF OSTEOCALCIN [J].
EGUCHI, H ;
HOSODA, K ;
KURIHARA, N ;
NAKAMOTO, T ;
KOBAYASHI, S ;
ARITA, M ;
HASEGAWA, R ;
OHTA, T ;
KIYOKI, M ;
YAMAJI, T ;
SHIRAKI, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 184 (02) :231-240
[5]   CARBOXYLATED CALCIUM-BINDING PROTEINS AND VITAMIN-K [J].
GALLOP, PM ;
LIAN, JB ;
HAUSCHKA, PV .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (26) :1460-1466
[6]   OSTEOCALCIN-HYDROXYAPATITE INTERACTION IN THE EXTRACELLULAR ORGANIC MATRIX OF BONE [J].
HAUSCHKA, PV ;
WIANS, FH .
ANATOMICAL RECORD, 1989, 224 (02) :180-188
[7]   DIRECT IDENTIFICATION OF CALCIUM-BINDING AMINO-ACID, GAMMA-CARBOXYGLUTAMATE, IN MINERALIZED TISSUE [J].
HAUSCHKA, PV ;
LIAN, JB ;
GALLOP, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (10) :3925-3929
[8]   Osteocalcin detection in aging serum and whole blood: Stability of different osteocalcin fractions [J].
Knapen, MHJ ;
Eisenwiener, HG ;
Vermeer, C .
CLINICA CHIMICA ACTA, 1996, 256 (02) :151-164
[9]   Serum osteocalcin and bone mineral density at various skeletal sites: A study performed with three different assays [J].
Minisola, S ;
Rosso, R ;
Romagnoli, E ;
DErasmo, E ;
Manfredi, G ;
Damiani, C ;
DeAntoni, F ;
Mazzuoli, G .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 129 (04) :422-429
[10]  
Noonan K, 1996, EUR J CLIN CHEM CLIN, V34, P841